Valuation: GI Innovation, Inc.

Market Cap 452B 305M 268M 247M 228M 429M 29.45B 436M 2.96B 1.16B 14.41B 1.15B 1.12B 49.65B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 417B 282M 247M 228M 210M 396M 27.19B 403M 2.73B 1.07B 13.3B 1.06B 1.04B 45.84B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day-4.37%
1 week-10.94%
Current month-32.24%
1 month-39.39%
3 months-54.28%
6 months-51.66%
Current year-60.32%
1 week 6,950
Extreme 6950
7,910
1 month 6,950
Extreme 6950
12,130
Current year 6,950
Extreme 6950
18,830
1 year 6,950
Extreme 6950
21,550
3 years 6,809.09
Extreme 6809.0909
24,900
5 years 6,809.09
Extreme 6809.0909
24,900
10 years 6,809.09
Extreme 6809.0909
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 63 01/03/2022
Date Insider Type Main position Quantity % Market Cap.
1/20/26 A Fiscal year 809 0.0013%
1/20/26 A Fiscal year

Chief Technology Officer

445 0.0007%
1/20/26 A Expiration 89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-4.37%-10.94%-67.37%-29.03% 305M
-0.49%-4.01%-0.84%+2.28% 48.71B
-3.10%-1.94%+370.99%+572.60% 38.35B
-0.46%+2.18%+5.44%+61.01% 34.53B
-1.14%-1.76%+26.94%-9.93% 34.03B
-1.82%-1.43%+0.52%+31.85% 26.77B
-3.54%-5.08% - - 15.64B
-1.82%-0.43%+69.28%+113.82% 15.08B
+1.17%+2.30%+15.87%+18.26% 14.18B
-2.25%+0.05%+15.77%-32.83% 12.73B
Average -1.78%-2.00%+48.51%+80.89% 24.03B
Weighted average by Cap. -1.42%-1.24%+74.57%+116.79%

Financials

2024 2025
Net sales 24.28M 16.42K 14.39K 13.3K 12.24K 23.09K 1.58M 23.46K 159K 62.36K 775K 61.66K 60.31K 2.67M 5.84B 3.95M 3.46M 3.2M 2.94M 5.55M 381M 5.64M 38.25M 14.99M 186M 14.82M 14.5M 642M
Net income -58.78B -39.75M -34.84M -32.21M -29.62M -55.89M -3.83B -56.79M -385M -151M -1.88B -149M -146M -6.46B -35.13B -23.76M -20.83M -19.25M -17.7M -33.4M -2.29B -33.94M -230M -90.23M -1.12B -89.22M -87.27M -3.86B
Net Debt -3.44B -2.33M -2.04M -1.88M -1.73M -3.27M -224M -3.32M -22.53M -8.83M -110M -8.73M -8.54M -378M -34.63B -23.42M -20.52M -18.97M -17.45M -32.92M -2.26B -33.45M -227M -88.93M -1.1B -87.93M -86.01M -3.81B
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
20/07/26 ₩7,000.00 -4.37% 243,024
16/07/26 ₩7,320.00 -3.94% 283,373
15/07/26 ₩7,620.00 +3.96% 263,078
14/07/26 ₩7,330.00 -6.74% 381,232
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock